Prime Trust
Series B in 2022
Prime Trust LLC, based in Summerlin, Nevada, is a technology-driven trust company that offers innovative solutions for trust and custodial services. By developing software that serves as a financial infrastructure, Prime Trust enables fintech and digital asset companies to streamline their operations. As a chartered and regulated financial institution, it is subject to oversight by the banking commissioner’s office at the Financial Institutions Division. Prime Trust holds a diverse range of assets, including cash, stocks, bonds, cryptocurrencies, real estate, and private business interests. The company acts as a custodian and trustee for various personal and corporate trusts, playing a significant role in the crowdfunding industry. It collaborates with individuals, corporations, legal professionals, and investment advisers to provide specialized custodial, escrow, and trust services.
Halo Investing
Series C in 2021
Halo Investing, Inc. is a financial technology company based in Chicago, Illinois, that operates a multi-issuer platform focused on structured notes. Founded in 2015, the company aims to democratize access to structured notes, a sophisticated investment product typically available only to ultra-high-net-worth individuals. Halo provides advisory services to investment management firms, offering predefined investment strategies, customized note calendars, and portfolio diversification solutions tailored for financial advisors. Its platform enables clients to analyze, purchase, and manage structured notes throughout their lifecycle, enhancing efficiency for both investors and issuing banks. Additionally, Halo Investing manages securities and investment portfolios for individuals, pension plans, and profit-sharing plans.
Investment Counselors of MD
Acquisition in 2021
Investment Counselors of Maryland, LLC is a boutique investment advisory firm that employs an unwavering focus on value-driven investing.
Athersys, Inc. is a biotechnology company headquartered in Cleveland, Ohio, specializing in regenerative medicine. The company focuses on the research and development of therapeutic products aimed at treating various disease indications, including neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary issues. Its primary product, MultiStem cell therapy, is an allogeneic stem cell treatment currently undergoing Phase III clinical trials for ischemic stroke and Phase II trials for acute myocardial infarction. Additionally, MultiStem has completed Phase I trials concerning certain blood-borne cancers. Athersys is also dedicated to developing therapies for veterinary applications and has established collaboration agreements with Healios K.K. and the University of Minnesota to further advance its MultiStem platform in several disease contexts. The company has engaged in various revenue-generating activities, including corporate collaborations, licensing agreements, and government grants. Founded in 1995, Athersys is committed to addressing unmet medical needs through innovative biopharmaceuticals.
Athersys, Inc. is a biotechnology company headquartered in Cleveland, Ohio, specializing in regenerative medicine. The company focuses on the research and development of therapeutic products aimed at treating various disease indications, including neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary issues. Its primary product, MultiStem cell therapy, is an allogeneic stem cell treatment currently undergoing Phase III clinical trials for ischemic stroke and Phase II trials for acute myocardial infarction. Additionally, MultiStem has completed Phase I trials concerning certain blood-borne cancers. Athersys is also dedicated to developing therapies for veterinary applications and has established collaboration agreements with Healios K.K. and the University of Minnesota to further advance its MultiStem platform in several disease contexts. The company has engaged in various revenue-generating activities, including corporate collaborations, licensing agreements, and government grants. Founded in 1995, Athersys is committed to addressing unmet medical needs through innovative biopharmaceuticals.
Inuvo specializes in digital marketing solutions, connecting advertisers with targeted audiences across various online platforms such as video, mobile, display, social media, and native. Its key products include ValidClick for data-driven marketing services and IntentKey for reaching in-market consumers. Inuvo operates a network of websites like alot.com and earnspendlive.com, covering categories like health, finance, travel, and education. The company generates revenue through digital advertising placements across devices, websites, and applications.
TargeGen, Inc. is a biopharmaceutical company based in San Diego, California, founded in 2002. The company specializes in the discovery and development of small molecule kinase inhibitors aimed at addressing vascular leakage, vascular proliferation, and inflammation. TargeGen's products are designed for the treatment of various serious medical conditions, including heart attacks, cancer, and eye diseases. Specifically, their therapies target issues like vascular leakage, edema, unwanted growth of new blood vessels, pleural effusions, arthritis, pulmonary edema, transplant ischemia, acute respiratory distress syndrome, brain inflammation, and central nervous system disorders. The company has a particular focus on markets related to macular degeneration, diabetic macular edema, and diabetic retinopathy. In 2010, TargeGen was acquired by Sanofi Aventis.
HouseValues
Venture Round in 2004
HouseValues, founded in 1999 by a second-generation real estate agent, specializes in providing marketing and technology solutions tailored for real estate professionals. The company offers subscription-based software and advertising products designed to help real estate agents, agent teams, and brokerage firms generate a consistent flow of prospects. Additionally, HouseValues equips its clients with essential tools and training to effectively convert these prospects into clients, thereby enhancing their business growth and management capabilities in a competitive market.
Xan3D Technologies
Series C in 2004
Xan3D Technologies is a semiconductors manufacturer that uses hybrid integrated circuit technology to produce semiconductors for the data communications, telecommunications, and computing industries. By utilizing the optically integrated electronic circuit technology, Xan3D Technologies designs and manufactures optical connection products for next generation data links and optical communication applications.
Xan3D Technologies offers flexible networking and processing solutions for data communications, telecommunications, and computing markets. It is headquartered in Merrimack, New Hampshire.
NuVasive
Venture Round in 2004
NuVasive, Inc. is a medical device company that specializes in developing and marketing minimally disruptive surgical products and integrated solutions for spine surgery. Founded in 1997 and headquartered in San Diego, California, the company focuses on enhancing surgical outcomes through its portfolio, which includes surgical access instruments, spinal implants, fixation systems, and biologics. Key products feature the Maximum Access Surgery platform, which incorporates advanced nerve detection and intraoperative monitoring services. NuVasive also offers a range of specialized implants, including cellular bone matrices and synthetic bone substitutes, aimed at facilitating restorative and fusion procedures for both thoracolumbar and cervical spine applications. Additionally, the company provides innovative systems, such as the Integrated Global Alignment platform and magnetically adjustable implant systems, and serves a diverse clientele including patients, surgeons, hospitals, and insurers through various sales channels.
TargeGen, Inc. is a biopharmaceutical company based in San Diego, California, founded in 2002. The company specializes in the discovery and development of small molecule kinase inhibitors aimed at addressing vascular leakage, vascular proliferation, and inflammation. TargeGen's products are designed for the treatment of various serious medical conditions, including heart attacks, cancer, and eye diseases. Specifically, their therapies target issues like vascular leakage, edema, unwanted growth of new blood vessels, pleural effusions, arthritis, pulmonary edema, transplant ischemia, acute respiratory distress syndrome, brain inflammation, and central nervous system disorders. The company has a particular focus on markets related to macular degeneration, diabetic macular edema, and diabetic retinopathy. In 2010, TargeGen was acquired by Sanofi Aventis.
Primus Marketing
Venture Round in 2003
Primus Marketing is a manufacturer's representative that serves the electric utility, lighting, and telecommunications industries. They provide their customers with unrivaled market insights that help them select the right manufacturers and products for their needs thanks to their trusted relationships with these manufacturers. It has a long history in the power, lighting, and telecommunications industries.
CryoCor is a medical technology company based in San Diego that develops cryogenic solutions to treat cardiac rhythm disorders. Its flagship system, the CryoCor Cardiac Cryoablation System, is a catheter-based, minimally invasive device that creates electrically isolating lesions with cold energy to treat arrhythmias such as atrial fibrillation. The system comprises a cryoablation catheter connected to an articulating arm on a refrigeration console and can be used with introducer sheaths to facilitate catheter placement. By cooling tissue to about -90°C, it blocks abnormal electrical signals and helps restore normal heart rhythm. The technology is marketed for use in Europe, where it has been available since 2002 and is deployed at multiple medical centers under the management of the company’s European operations.
Chicken Out Rotisserie
Venture Round in 2002
Treating your family, your guests, and yourself to flavorful, high-quality, inexpensive meals has never been more convenient. At Chicken Out, they provide award-winning, always fresh, 100% all-natural chicken, served in a variety of scrumptious dishes, from platters to salads, from breasts to filets, and from sandwiches to soups to rotisserie on the bone. They marinate their chickens in a special blend of natural herbs and spices, slow rotisserie roast them to perfection, and serve them fresh and juicy.
To make your mealtime planning as simple as possible, Chicken Out provides many options for ordering. You can order online and pick up your meal at one of their local restaurants. Or, join us for in-house dining. Chicken Out also provides on-demand catering services. Call us, or email us, and they’ll provide a catered meal for a large group within two hours. And if you need the meal sooner, call us for immediate assistance.
Inhibitex
Venture Round in 2002
Inhibitex is a biotechnology company that specializes in the development of antibody-based products aimed at preventing and treating bacterial and fungal infections. The company is particularly focused on creating small molecule antiviral compounds, with specific attention to therapies for shingles, also known as herpes zoster, and chronic hepatitis C infections. Through its innovative approach, Inhibitex seeks to address significant medical needs in the realm of infectious diseases.
Xan3D Technologies
Series B in 2002
Xan3D Technologies is a semiconductors manufacturer that uses hybrid integrated circuit technology to produce semiconductors for the data communications, telecommunications, and computing industries. By utilizing the optically integrated electronic circuit technology, Xan3D Technologies designs and manufactures optical connection products for next generation data links and optical communication applications.
Xan3D Technologies offers flexible networking and processing solutions for data communications, telecommunications, and computing markets. It is headquartered in Merrimack, New Hampshire.
Extended Care Information Network
Private Equity Round in 2001
Extended Care Information Network is a software and consulting company serving hospital case management and discharge planning in the United States. It offers web-based tools for discharge planning, utilization management, and patient referrals to streamline workflow, improve productivity, and reduce length of stay. Its product suite includes ExtendedCare Professional Discharge Planning, ExtendedCare Professional Utilization and Case Management, ExtendedCare Provider Access for electronically receiving referrals from hospitals, and the Referral Assistance Program to identify and communicate post-acute care options. The company also provides project management, implementation, client support, call center, and consulting services to support adoption and ongoing operations. Founded in 1995 and based in Chicago, Illinois, the organization focuses on helping hospitals coordinate care across inpatient and post-acute settings, with emphasis on improving patient throughput and facilitating reimbursement.
PDQuick
Venture Round in 2000
PDQuick, a direct-to-home delivery e-tailer.
American Blinds and Wallpaper And More
Venture Round in 2000
American Blinds and Wallpaper Factory, Inc. is a direct marketer of home decorating products in the United States, specializing in a wide range of offerings including window blinds, wallpapers, curtains, and rugs. The company provides various types of blinds and shades, such as wood, faux wood, pleated, and vertical blinds, as well as interior shutters. In addition to these products, American Blinds offers wallpapers, wall decals, and a selection of decorative accessories for various spaces, including residential, commercial, and hospitality environments. The company features a custom digitalized design program that allows customers to create tailored designs according to their specifications. Established in 1993 and headquartered in Houston, Texas, American Blinds markets its products through both retail outlets and an online platform, catering to diverse sectors such as healthcare, education, and corporate interiors.
Interactive Information Service
Venture Round in 2000
Interactive Information Service provides advanced HR-focused process automation solutions. It was founded in 2000 and is based in Cleveland, Ohio.
Extended Care Information Network
Venture Round in 2000
Extended Care Information Network is a software and consulting company serving hospital case management and discharge planning in the United States. It offers web-based tools for discharge planning, utilization management, and patient referrals to streamline workflow, improve productivity, and reduce length of stay. Its product suite includes ExtendedCare Professional Discharge Planning, ExtendedCare Professional Utilization and Case Management, ExtendedCare Provider Access for electronically receiving referrals from hospitals, and the Referral Assistance Program to identify and communicate post-acute care options. The company also provides project management, implementation, client support, call center, and consulting services to support adoption and ongoing operations. Founded in 1995 and based in Chicago, Illinois, the organization focuses on helping hospitals coordinate care across inpatient and post-acute settings, with emphasis on improving patient throughput and facilitating reimbursement.
Proteome
Venture Round in 2000
Proteome is a privately held company specializing in proteomics information, focusing on the development of an integrated biological knowledge system that aids researchers in understanding gene and protein functions. The company's flagship product, the BioKnowledge Library, serves as a comprehensive database containing annotations for over 50,000 proteins across various organisms, including humans, rats, mice, worms, and yeast. This extensive library is curated by a network of nearly 100 scientists, ensuring high-quality and reliable data. Additionally, Proteome provides tools that transform scientific publications into analyzable relational data, facilitating sophisticated online searches for protein analysis and supporting the scientific community in their research endeavors.
THINQ Learning Solutions
Series C in 2000
THINQ Learning Solutions is the number one business to business e-commerce marketplace for skills training and professional education, with the most comprehensive selection of all brands and forms of training, including classroom, on-site, and online training, books, videos and CD-ROMs. Through a partnership-oriented strategy, THINQ Learning Solutions is making its marketplace accessible where professionals already go for career development: corporate intranets; the career sections of high-traffic Web sites; business and professional-oriented Web sites, and THINQ Learning Solutions own public Web site.
FOB.com
Venture Round in 2000
The Flying Other Brothers were an American rock band active from 1997–2006 in San Francisco. The band played original tunes and covers.
The band started at an Electronic Frontier Foundation (EFF) benefit at The Fillmore Auditorium in 1997. At this time the band included Roger McNamee, a venture capitalist; Giles McNamee, investment banker, board member of EFF and Roger's brother; guitarist Bert Keely of Microsoft; Bill Bennett, a marketing and communications strategist; and Tony Bove (rechristened "TBone"), author of books about computers and the Internet. The band had its roots in acoustic performances Roger and Giles McNamee gave as the Other Brothers in lounges around New England during the early 1980s.
Practicity
Series A in 1999
Practicity focuses exclusively on the development, delivery and support of innovative software solutions for professional service organizations that "web-enable" front-end client acquisition, service delivery and re-engagement activities.
Practicity (formerly IntegrationWare) pioneered browser-based information sharing and knowledge management. Its web-based solutions have been tested and refined in client engagements since 1993. The Practicity management team combines first-hand knowledge of the professional services business with extensive realworld experience in object-oriented applications development, human-computer interface design and web based computing.
Apropos Technology
Series C in 1998
Apropos Technology, Inc. is a software company that specializes in multichannel interaction management applications. The company’s products facilitate customer interactions across various communication platforms, including email, fax, web, and voice. By enabling online customers to engage with businesses through the internet and offering access to human assistance via interactive web chat or voice interaction, Apropos Technology enhances the customer experience during sales and service transactions.